The TransMed7 team was most delighted to initiate the “soft” launch of its primary breast platform devices, SpeedBirdTM and ConcordeTM including SpeedBird
TransMed7, LLC announced today the availability of Concorde, the stereotactic table variant of its SpeedBird Biopsy Device Platform “We are delighted
TransMed7, LLC is delighted to announce the appointment of Carin Fradin as a member of its Business Advisory Board Ms. Fradin
TransMed7, LLC is delighted to announce the appointment of Michael J. Cyrus as a member of its Business Advisory Board Mr.
TransMed7, LLC is delighted to announce the appointment of John B. Simpson, Ph.D., M.D., as Strategic Advisor to the TransMed7 Board of
TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its SpeedBird Soft Tissue Biopsy Device Platform TransMed7, LLC announced today
TransMed7, LLC Announces Strategic Engagement with Wilson Sonsini Goodrich and Rosati TransMed7, LLC, announced a Strategic Engagement with the firm of